Published in Healthcare Mergers, Acquisitions and Ventures Week, September 8th, 2007
Adams Respiratory Therapeutics' CEO Michael J. Valentino said, "I am extremely pleased that Adams was ranked seventh overall, out of the companies honored in Deloitte's Technology Fast 50 program. We...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.